AzTrials
AzTrials

Low Back PainPhase 4LBPNCT00444990

Study on Magnetic Field Therapy to Improve Chronic Lumbar Pain

A Phase 4 study testing Magnetic Flex Pad in people with Low Back Pain, run by Weintraub, Michael I., MD, FACP, FAAN at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

OBJECTIVE: The objective of this study is to determine if treatment with a flex pad impregnated with static/permanent magnets that can penetrate over 70 mm may improve the quality of chronic lumbar pain with reduction of pain scores. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Low Back Pain
What is being tested?
Magnetic Flex Pad
Type of treatment
Medical device
How many people
60 participants
Where
1 siteUnited States
Study dates
Feb 2007to Dec 2007
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Female or male subjects age 18-80.
  • Capable of understanding and complying with study protocols.
  • Chronic lumbar pain for at least six months

Who cannot join

  • Unable to understand informed consent (mental retardation, psychosis, communicative impairment).
  • Cardiac pacemaker or other mechanical internal devices.
  • Tumor in the spine/history of malignancy or tumor.
  • Pregnancy.
  • Prior spine surgery.

Trial locations and contacts

1 site in 1 country.

Michael I Weintraub, MD contact

914-941-0788

miwneuro@pol.net

Susan E. Wolert contact

914-941-0788

miwneuro@pol.net

United States1 site, 1 recruiting
  • Michael I. Weintraub, MD

    Briarcliff Manor, New York, 10510

    Michael I Weintraub, MD, 914-941-0788, miwneuro@pol.net

    Susan E Wolert, 914-941-0788, miwneuro@pol.net

    Recruiting

Other trials in United States

About this study

Official title: A Double-Blind, Randomized, Placebo-Controlled Study on Magnetic Field Therapy to Improve Chronic Lumbar Pain (Lbp)

OBJECTIVE:

The objective of this study is to determine if treatment with a flex pad impregnated with static/permanent magnets that can penetrate over 70 mm may improve the quality of chronic lumbar pain with reduction of pain scores.

HYPOTHESIS:

The researchers hypothesis that the application of a flex pad active magnetic therapy vs. sham if utilized daily during waking hours can reduce back pain and/or radicular pain. The null hypothesis is that treatment of subjects with chronic back pain with exposure to static/permanent magnetic fields have no measurable effect on chronic back pain scores and will be equal to the underlying placebo.

Read the detailed description

DESIGN:

This is a double-blind, randomized, placebo-controlled study which will consist of two treatment groups. Treated subjects will receive a static/permanent magnetic flex pad with a nominal strength of less than 1000 Gauss. Control subjects will receive physically identical flex pad without magnet with a nominal surface field strength of 0 Gauss (placebo). The magnets will be contained in a pad with a Velcro cover and subjects will wear the pad attached to their undergarments/skin during waking hours. Dr. Weintraub will examine participants initially to look for presence or absence of radiculitis, range of motion, presence of absence of spasm, etc. The primary outcome measures will be reduction of chronic low back pain in comparison with prior baseline scores. It is recognized that these changes are subjective in nature. Patients will maintain their VAS scores on a monthly basis and at the end of the study, individuals will return all forms and be reevaluated by Dr. Weintraub. They will be asked specific questions regarding PGIC for bias, etc.

Conditions
Low Back Pain
Being tested
Magnetic Flex Pad
Keywords
Lumbar pain, magnets, Reduce low back pain
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Magnetic Flex PadDevice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. VAS Pain scores/ SF 15 Pain descriptors/ PGIF/

Secondary outcomes (1)
  1. Autonomic nervous system functions and range of motion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Mar 2007 (estimated)
  2. Study startFeb 2007
  3. Study completionDec 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00444990
Sponsor's protocol ID
00781441
Acronym
LBP
Status last verified
Sep 2007
First submitted
6 Mar 2007
Last updated
21 Sep 2007
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Magnetic Flex Pad in people with Low Back Pain, run by Weintraub, Michael I., MD, FACP, FAAN at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Sep 2007. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Michael I Weintraub, MD (914-941-0788, miwneuro@pol.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

VAS Pain scores/ SF 15 Pain descriptors/ PGIF/. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2007.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in